Extrawell Pharmaceutical Grants 76.5 Million Options Under Incentive Scheme; Shares Slip 4%
MT Newswires Live
Dec 22, 2025
Extrawell Pharmaceutical (HKG:0858) will grant 76.5 million share options to three executive directors under a 2022 incentive scheme, a Dec. 19 Hong Kong bourse filing said.
Shares of the pharmaceutical company were down over 4% in Monday afternoon trading.
The options are exercisable into 76.5 million ordinary shares at HK$0.0936 apiece for 10 years. The shares represent 3% of the firm's issued shares.
Following the grant, the company now has 162.5 million share options available for future grant under the existing scheme mandate limit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.